Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Merz_Pharma> ?p ?o. }
Showing items 1 to 30 of
30
with 100 items per page.
- Merz_Pharma abstract "Merz Pharma GmbH & Co. KGaA is an international healthcare company specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. Based in Frankfurt am Main, Germany, Merz is a leader in the field of Alzheimer's disease research and developed memantine as the first drug for the treatment of moderate to severe Alzheimer's disease. Other franchises covered by Merz are hepatology / metabolic diseases and dermatology (including Mederma scar gel). In Asia Pacific, the Merz franchise covers aesthetic dermatology (including Radiesse and Xeomin).Merz was founded in 1908, has 1700 employees and had 580 million euros of sales in 2008/09. The US subsidiary of Merz is Merz Pharmaceuticals LLC in Greensboro, North Carolina.".
- Merz_Pharma wikiPageExternalLink www.merz.com.
- Merz_Pharma wikiPageID "4388776".
- Merz_Pharma wikiPageRevisionID "600806650".
- Merz_Pharma hasPhotoCollection Merz_Pharma.
- Merz_Pharma subject Category:1908_establishments_in_Germany.
- Merz_Pharma subject Category:Pharmaceutical_companies_established_in_1908.
- Merz_Pharma subject Category:Pharmaceutical_companies_of_Germany.
- Merz_Pharma type Abstraction100002137.
- Merz_Pharma type CompaniesEstablishedIn1908.
- Merz_Pharma type Company108058098.
- Merz_Pharma type DrugCompany108002578.
- Merz_Pharma type Group100031264.
- Merz_Pharma type Institution108053576.
- Merz_Pharma type Organization108008335.
- Merz_Pharma type PharmaceuticalCompaniesOfGermany.
- Merz_Pharma type SocialGroup107950920.
- Merz_Pharma type YagoLegalActor.
- Merz_Pharma type YagoLegalActorGeo.
- Merz_Pharma type YagoPermanentlyLocatedEntity.
- Merz_Pharma comment "Merz Pharma GmbH & Co. KGaA is an international healthcare company specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. Based in Frankfurt am Main, Germany, Merz is a leader in the field of Alzheimer's disease research and developed memantine as the first drug for the treatment of moderate to severe Alzheimer's disease.".
- Merz_Pharma label "Merz Pharma".
- Merz_Pharma label "Merz Pharma".
- Merz_Pharma sameAs Merz_Pharma.
- Merz_Pharma sameAs m.0b_mjj.
- Merz_Pharma sameAs Q1476687.
- Merz_Pharma sameAs Q1476687.
- Merz_Pharma sameAs Merz_Pharma.
- Merz_Pharma wasDerivedFrom Merz_Pharma?oldid=600806650.
- Merz_Pharma isPrimaryTopicOf Merz_Pharma.